Cargando…
Enhancing antibody folding and secretion by tailoring the Saccharomyces cerevisiae endoplasmic reticulum
BACKGROUND: The yeast Saccharomyces cerevisiae provides intriguing possibilities for synthetic biology and bioprocess applications, but its use is still constrained by cellular characteristics that limit the product yields. Considering the production of advanced biopharmaceuticals, a major hindrance...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878073/ https://www.ncbi.nlm.nih.gov/pubmed/27216259 http://dx.doi.org/10.1186/s12934-016-0488-5 |
_version_ | 1782433505844658176 |
---|---|
author | de Ruijter, Jorg C. Koskela, Essi V. Frey, Alexander D. |
author_facet | de Ruijter, Jorg C. Koskela, Essi V. Frey, Alexander D. |
author_sort | de Ruijter, Jorg C. |
collection | PubMed |
description | BACKGROUND: The yeast Saccharomyces cerevisiae provides intriguing possibilities for synthetic biology and bioprocess applications, but its use is still constrained by cellular characteristics that limit the product yields. Considering the production of advanced biopharmaceuticals, a major hindrance lies in the yeast endoplasmic reticulum (ER), as it is not equipped for efficient and large scale folding of complex proteins, such as human antibodies. RESULTS: Following the example of professional secretory cells, we show that inducing an ER expansion in yeast by deleting the lipid-regulator gene OPI1 can improve the secretion capacity of full-length antibodies up to fourfold. Based on wild-type and ER-enlarged yeast strains, we conducted a screening of a folding factor overexpression library to identify proteins and their expression levels that enhance the secretion of antibodies. Out of six genes tested, addition of the peptidyl-prolyl isomerase CPR5 provided the most beneficial effect on specific product yield while PDI1, ERO1, KAR2, LHS1 and SIL1 had a mild or even negative effect to antibody secretion efficiency. Combining genes for ER enhancement did not induce any significant additional effect compared to addition of just one element. By combining the Δopi1 strain, with the enlarged ER, with CPR5 overexpression, we were able to boost the specific antibody product yield by a factor of 10 relative to the non-engineered strain. CONCLUSIONS: Engineering protein folding in vivo is a major task for biopharmaceuticals production in yeast and needs to be optimized at several levels. By rational strain design and high-throughput screening applications we were able to increase the specific secreted antibody yields of S. cerevisiae up to 10-fold, providing a promising strain for further process optimization and platform development for antibody production. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-016-0488-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4878073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-48780732016-05-25 Enhancing antibody folding and secretion by tailoring the Saccharomyces cerevisiae endoplasmic reticulum de Ruijter, Jorg C. Koskela, Essi V. Frey, Alexander D. Microb Cell Fact Research BACKGROUND: The yeast Saccharomyces cerevisiae provides intriguing possibilities for synthetic biology and bioprocess applications, but its use is still constrained by cellular characteristics that limit the product yields. Considering the production of advanced biopharmaceuticals, a major hindrance lies in the yeast endoplasmic reticulum (ER), as it is not equipped for efficient and large scale folding of complex proteins, such as human antibodies. RESULTS: Following the example of professional secretory cells, we show that inducing an ER expansion in yeast by deleting the lipid-regulator gene OPI1 can improve the secretion capacity of full-length antibodies up to fourfold. Based on wild-type and ER-enlarged yeast strains, we conducted a screening of a folding factor overexpression library to identify proteins and their expression levels that enhance the secretion of antibodies. Out of six genes tested, addition of the peptidyl-prolyl isomerase CPR5 provided the most beneficial effect on specific product yield while PDI1, ERO1, KAR2, LHS1 and SIL1 had a mild or even negative effect to antibody secretion efficiency. Combining genes for ER enhancement did not induce any significant additional effect compared to addition of just one element. By combining the Δopi1 strain, with the enlarged ER, with CPR5 overexpression, we were able to boost the specific antibody product yield by a factor of 10 relative to the non-engineered strain. CONCLUSIONS: Engineering protein folding in vivo is a major task for biopharmaceuticals production in yeast and needs to be optimized at several levels. By rational strain design and high-throughput screening applications we were able to increase the specific secreted antibody yields of S. cerevisiae up to 10-fold, providing a promising strain for further process optimization and platform development for antibody production. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12934-016-0488-5) contains supplementary material, which is available to authorized users. BioMed Central 2016-05-23 /pmc/articles/PMC4878073/ /pubmed/27216259 http://dx.doi.org/10.1186/s12934-016-0488-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research de Ruijter, Jorg C. Koskela, Essi V. Frey, Alexander D. Enhancing antibody folding and secretion by tailoring the Saccharomyces cerevisiae endoplasmic reticulum |
title | Enhancing antibody folding and secretion by tailoring the Saccharomyces cerevisiae endoplasmic reticulum |
title_full | Enhancing antibody folding and secretion by tailoring the Saccharomyces cerevisiae endoplasmic reticulum |
title_fullStr | Enhancing antibody folding and secretion by tailoring the Saccharomyces cerevisiae endoplasmic reticulum |
title_full_unstemmed | Enhancing antibody folding and secretion by tailoring the Saccharomyces cerevisiae endoplasmic reticulum |
title_short | Enhancing antibody folding and secretion by tailoring the Saccharomyces cerevisiae endoplasmic reticulum |
title_sort | enhancing antibody folding and secretion by tailoring the saccharomyces cerevisiae endoplasmic reticulum |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878073/ https://www.ncbi.nlm.nih.gov/pubmed/27216259 http://dx.doi.org/10.1186/s12934-016-0488-5 |
work_keys_str_mv | AT deruijterjorgc enhancingantibodyfoldingandsecretionbytailoringthesaccharomycescerevisiaeendoplasmicreticulum AT koskelaessiv enhancingantibodyfoldingandsecretionbytailoringthesaccharomycescerevisiaeendoplasmicreticulum AT freyalexanderd enhancingantibodyfoldingandsecretionbytailoringthesaccharomycescerevisiaeendoplasmicreticulum |